Three core cancer Research Programs that bring investigators in cancer biology, therapeutics, and population science have been established. They are:
Each of these Programs meets every two weeks. Their membership draws from Brown University, the Warren Alpert Medical School, the Brown School of Public Health, the Lifespan Cancer Institute, Rhode Island Hospital, The Miriam Hospital, Women & Infants Hospital, and the Providence VA Medical Center, among others. These research groups are intended to capture all cancer-relevant research within the university, academic medical center, and throughout the affiliated hospitals.
In addition to identifying thematic areas, the group meetings facilitate members becoming familiar with research across their group as well as other groups. It's also expected that group members will collaborate and will generate intra-programmatic and inter-programmatic publications. This type of collaboration has been happening for years at this academic center and hospitals, and these groups will help enhance and expand these activities.
The expectations of members are largely driven by our collective interest in cancer and the desire to promote intra- and inter-programmatic collaboration:
- Effort to attend group meetings of interest and participate in discussions.
- Willingness to collaborate with colleagues, including pursuit of translational directions.
- Willingness to speak at meetings when invited.
- Willingness to provide updates about their research including NIH biosketches and brief summaries.
- Participation in multi-investigator grant submissions.
Benefits of Membership
There are benefits to membership in cancer research programs and these include eligibility to apply for certain pilot funds that will be announced periodically. Members can interact and collaborate with colleagues across the institutions and across the cancer programs. Other benefits as a center evolves include often discounted access to innovative core resources. NCI-funded centers allow members to compete for supplemental funds the NCI provides each year through RFAs, access to national resources such as CTEP drugs, clinical trial resources and opportunity for membership and access to research resources that are generated by various national consortiums. These are significant and support the whole cancer research mission from cell lines, mouse models, chemical libraries, and support for various types of therapeutic and prevention clinical trials.
If you wish to be included in one of the cancer research groups, please contact:
Wafik El-Deiry, MD, PhD
Director, Cancer Center at Brown University
Associate Dean for Oncologic Sciences